Vikki A. Canfield

University of Oklahoma Health Sciences Center — United States

Medicine · Health Sciences

9h-index209citations20works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(5), Cancer therapeutics and mechanisms(4), Lung Cancer Research Studies(4), Breast Cancer Treatment Studies(3), Head and Neck Cancer Studies(3)

Publications20 total

The development of a culturally sensitive brochure on breast health for American Indian women
European Journal of Public Health·2018· 1 cited
The development of a culturally sensitive brochure on breast health for American Indian women
European Journal of Public Health·2018· 1 cited
Abstract OT3-04-01: BRE12-158: A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer (TNBC)
Cancer Research·2017· 4 cited
METRIC: A randomized international study of the antibody-drug conjugate glembatumumab vedotin (GV or CDX-011) in patients (pts) with metastatic gpNMB-overexpressing triple-negative breast cancer (TNBC).
Journal of Clinical Oncology·2015· 9 cited
Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by Chemoradiotherapy
The Laryngoscope·2008· 14 cited
The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC) renal cell carcinoma (RCC)
Journal of Clinical Oncology·2007· 41 cited
ZD9331 as Second- or Third-Line Therapy in Patients With Advanced Colorectal Cancer
American Journal of Clinical Oncology·2004· 12 cited
Sinonasal neuroendocrine carcinoma in association with SIADH
Head & Neck·2003· 24 cited
Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck
American Journal of Otolaryngology·2003· 9 cited
A phase II Trial of Weekly Paclitaxel, 5-Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Breast Cancer
Breast Cancer Research and Treatment·2003· 3 cited
Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study
Breast Cancer Research and Treatment·1998· 14 cited
A Phase II Trial of Vinorelbine in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
American Journal of Clinical Oncology·1998· 22 cited
Teniposide (VM‐26) as a single drug treatment for patients with extensive small cell lung carcinoma
Cancer·1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
PubMed·1997· 9 cited
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma
Cancer·1997· 8 citedOpen Access
2-Chlorodeoxyadenosine as Initial Therapy for Advanced Low Grade Lymphomas
Leukemia & lymphoma/Leukemia and lymphoma·1997· 10 cited
A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer
Investigational New Drugs·1993· 2 cited
An unusual mediastinal tumor in a patient with aids
The American Journal of Medicine·1993· 6 cited
CHEMOTHERAPY IN THE MANAGEMENT OF MALIGNANT GASTROINTESTINAL DISEASE
Gastroenterology Clinics of North America·1992
Isolation and characterization of the α and β chains of human platelet glycoprotein Ib
Biochemical and Biophysical Research Communications·1987· 20 cited

Frequent Co-authors

Jesús E. Medina(3), P Grozea(3), John J. Crowley(3), Laura Kingsbury(3), Sydney Ross(3), Germán Beltrán(3), Leslie Rodgers Laufman(3), Geoffrey R. Weiss(3), Robert B. Livingston(3), Eleni L. Tolma(2), Cara Thomas(2), Norma Neely(2), E Chery(2), T Edwards(2), Walter M. Stadler(1), Robert A. Figlin(1), Marc S. Ernstoff(1), Brendan D. Curti(1), Kelly Pendergrass(1), S. Srinivas(1)